findmyKOL
Clinical trialNCT04254939CompletedPhase 1/PHASE2Interventional

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

SponsorCStone PharmaceuticalsEnrollment65Gastrointestinal Stromal Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China

  • Chinese Pla General Hospital

    Beijing, Beijing Municipality, China

  • the First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

  • the First Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • the Sixth Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China

  • Wuhan Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • the First Affiliated Hospital of Nanchang Medical University

    Nanchang, Jiangxi, China

  • Liaoning Cancer Hospital & Institute

    Shenyang, Liaoning, China

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, China

  • Fudan University Zhongshan Hospital (general Surgery Department)

    Shanghai, Shanghai Municipality, China

  • Fudan University Zhongshan Hospital (internal Tumor Department)

    Shanghai, Shanghai Municipality, China

  • Renji Hospital Affiliated To Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Xinjiang Medical University Cancer Hospital

    Ürümqi, Xinjiang, China

  • the First Affiliated Hospital Zhe Jiang University

    Hangzhou, Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2019
Primary completion
30 Apr 2020
Completion
11 Apr 2023
Last update posted
27 Apr 2023
Registered enrollment
65
Registry id
NCT04254939

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.